FARBRIDGE PHARMA CONSULTING Trademark
Trademark Overview
On Monday, January 22, 2024, a trademark application was filed for FARBRIDGE PHARMA CONSULTING with the United States Patent and Trademark Office. The USPTO has given the FARBRIDGE PHARMA CONSULTING trademark a serial number of 98369306. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, January 16, 2025. This trademark is owned by Farbridge Pharma Consulting, LLC. The FARBRIDGE PHARMA CONSULTING trademark is filed in the Computer & Software Services & Scientific Services, Personal and Legal & Social Services categories with the following description:
Regulatory compliance consulting in the field of drug and device development and manufacturing
Consulting services in the field of biotechnology; Consulting services in the field of genetic science; Consulting services in the field of pharmaceutical research and development; Pharmaceutical drug development services
General Information
| Serial Number | 98369306 |
| Word Mark | FARBRIDGE PHARMA CONSULTING |
| Filing Date | Monday, January 22, 2024 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Thursday, January 16, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of A whirlpool symbol that changes from light blue to a darker blue as you follow the symbol's swirl in a clockwise direction and with the words "FARBRIDGE PHARMA CONSULTING" in white to the right of the symbol. |
| Indication of Colors claimed | The color(s) blue and white is/are claimed as a feature of the mark. |
| Goods and Services | Regulatory compliance consulting in the field of drug and device development and manufacturing |
| NOT AVAILABLE | "Pharma Consulting" |
| Goods and Services | Consulting services in the field of biotechnology; Consulting services in the field of genetic science; Consulting services in the field of pharmaceutical research and development; Pharmaceutical drug development services |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 22, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, July 17, 2023 |
| First Use In Commerce Date | Monday, July 17, 2023 |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 22, 2024 |
| Primary Code | 045 |
| First Use Anywhere Date | Monday, July 17, 2023 |
| First Use In Commerce Date | Monday, July 17, 2023 |
Trademark Owner History
| Party Name | Farbridge Pharma Consulting, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | San Diego, CA 92120 |
Trademark Events
| Event Date | Event Description |
| Monday, January 22, 2024 | NEW APPLICATION ENTERED |
| Wednesday, May 22, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, May 22, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, August 16, 2024 | ASSIGNED TO EXAMINER |
| Monday, August 19, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, August 19, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, January 16, 2025 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Thursday, January 16, 2025 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Monday, August 19, 2024 | NON-FINAL ACTION WRITTEN |
